can we still get tirzepatide Now that shortages of semaglutide and are resolved, you may wonder if compounded GLP-1s are going away. Here's why they haven't disappeared entirely. 🔗 Check GoodRx for savings at the link People Who Stopped Taking the

Overall, the benefit-risk profile supports broad use of GLP-1-based therapies in MASLD across most patient subgroups, with individualized monitoring plans for high-risk populations

The imbalance contributes to systemic inflammation that can accelerate joint degeneration and reduce the effectiveness of treatments like hyaluronic acid

severe low potassium during rapid correction of severe anemiaseek urgent care for concerning symptoms (MedlinePlus)

By staying informed, maintaining rigorous standards, and prioritizing safety, health professionals can effectively support clients navigating this exciting frontier of metabolic medicine

Your provider can explain which option fits your history, your goals, and your tolerance